Serum Levels of Soluble P‐Selectin Are Increased and Associated With Disease Activity in Patients With Behçet′s Syndrome
Open Access
- 1 January 2005
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2005 (4) , 237-241
Abstract
Behçet′s syndrome (BS) is a relapsing, chronic, inflammatory disease characterized by endothelial dysfunction, atherothromboembogenesis, and leukocytoclastic vasculitis with complex immunologic molecular interactions. Generalized derangements of the lymphocyte and neutrophil populations, activated monocytes, and increased PMNLs motility with upregulated cell surface molecules such as ICAM‐1, VCAM‐1, and E‐selectin, which are found on the endothelial cells, leukocytes, and platelets, have all been demonstrated during the course of BS. Our aim is to investigate the association of serum concentrations of soluble P‐selectin in patients with BS, and to evaluate whether disease activity has an effect on their blood levels. This multicenter study included 31 patients with BS (15 men and 16 women) and 20 age‐ and sex‐matched healthy control volunteers (11 men and nine women). Neutrophil count, erythrocyte sedimentation rate, and acute‐phase reactants as well as soluble P‐selectin levels were determined. The mean age and sex distributions were similar (P > .05) between BS patients (35 years) and control volunteers (36 years). Serum levels of soluble P‐selectin in patients with BS (399 ± 72 ng/mL) were significantly (P < .001) higher when compared with control subjects (164 ± 40 ng/mL). In addition, active BS patients (453 ± 37 ng/mL) had significantly (P < .001) elevated levels of soluble P‐selectin than those in inactive period (341 ± 52 ng/mL). This study clearly demonstrated that serum soluble P‐selectin levels are increased in BS patients when compared with control subjects, suggesting a modulator role for soluble P‐selectin during the course of platelet activation and therefore, atherothrombogenesis formation in BS, especially in active disease.Keywords
This publication has 36 references indexed in Scilit:
- Serum‐Soluble Selectin Levels in Patients with Rheumatoid Arthritis and Systemic SclerosisScandinavian Journal of Immunology, 2004
- P-selectin suppresses hepatic inflammation and fibrosis in mice by regulating interferon γ and the IL-13 decoy receptorHepatology, 2004
- Managing the symptoms of Behçet’s diseaseExpert Opinion on Pharmacotherapy, 2004
- Platelet Activation Markers and Soluble Adhesion Molecules in Patients with Systemic Lupus ErythematosusAutoimmunity, 2001
- Selectin adhesion molecules in Behçet's diseaseAnnals of the Rheumatic Diseases, 2000
- Behçet's DiseaseNew England Journal of Medicine, 1999
- Behçet’s disease and complex aphthosisJournal of the American Academy of Dermatology, 1999
- Expression of endoglin in the transition between psoriatic uninvolved and involved skinActa Dermato-Venereologica, 1998
- Impaired haemostatic kinetics and endothelial function in Behçet's diseaseJournal of Internal Medicine, 1996
- Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent plateletsNature, 1992